By Steve Heap / Shutterstock.com

House Passes Bill to Help USPS Block International Shipments With Illegal Opioids

The Postal Service typically has no advanced data on the packages it receives from overseas.

The House on Thursday easily approved a measure to overhaul the international mailing system in an effort to shed the U.S. Postal Service’s reputation as an unwitting drug courier and reduce its role in the nation’s opioid crisis.

Many lawmakers and stakeholders have for years pushed the reform, which would require USPS to receive “advanced electronic data” on the contents of international packages before they reach the United States, but the Securing the International Mail Against Opioids Act (H.R. 5788) was only brought to a vote after a bipartisan, bicameral agreement broke through last week. Supporters of the measure were hopeful it would help stem the flow of illicit, synthetic opioids from foreign manufacturers through the mail system.

The legislation would bring requirements currently enforced on private shipping companies to the Postal Service by 2021, when the mailing agency would transmit the advanced data, or AED, to Customs and Border Protection on 100 percent of international packages. USPS, which currently only collects the data on 40 percent of inbound international packages, would have to pass on the information on 70 percent of packages by the end of this year. The agency would face civil penalties starting in 2021 if it continues to allow international shipments without AED to enter the country. Most foreign packages would face a $1 fee to cover the costs of additional customs processing.

The bill would have far-reaching impacts across the federal government. CBP is responsible for inspecting the packages at USPS’ international mail facilities, though investigations can incorporate Immigration and Customs Enforcement’s Homeland Security Investigations, the Drug Enforcement Agency, USPS’ Postal Inspection Service and other federal offices. The House bill would require the State Department to negotiate international agreements that require foreign countries to provide AED before sending packages. USPS, CBP and other agencies would be tasked with collaborating to develop new technology to help customs officers better detect illicit drugs in the mail.

CBP has often stressed the challenges associated with its task, likening the process of finding small batches of potentially deadly synthetic opioids to finding a “needle in a pile of needles in a needle factory.”

The agency currently relies primarily on canine teams to find packages containing illicit drugs. Robert Perez, CBP’s executive assistant commissioner for operations support, told Government Executive in an interview last year that front-line personnel rely on analytics based on synthesized information gathered throughout the government’s law enforcement arm to better identify what to look for when searching for illegal materials. That is coupled with and updated by CBP’s own observations in the field, as officers adjust to the new practices adopted by drug traffickers.

CBP maintains a presence at international shipping centers operated by both private carriers and the Postal Service, though under a law enacted after 9/11, only the private carriers are currently required to provide AED. That gives customs officers insight into who is sending the packages and allows them to flag questionable content lists based on their knowledge of how the traffickers operate. CBP’s National Targeting Center combs through the data on a daily basis and provides reports back to “advanced targeting teams” in the field, which then further analyze the information and filter it through the trends they see locally to help screeners identify packages for additional scrutiny.

USPS was, until recently, not providing that advanced data at all, and despite some pilot programs requiring the electronic information, still does so in a minority of cases. At international mail facilities, therefore, Perez said CBP officers operate on a “much more manual” basis. The agency asks the Postal Service to segregate mail originating from “countries of interest” and then begins a “manpower-intensive” process, including hand-picking out questionable packages and putting them through x-rays and other technologies front-line personnel employ.

Those individuals are looking not just for narcotics but violative content that runs “the full gambit of the CBP mission,” Perez explained.

“They’re the best at what they do,” Perez said. But still, private carriers shipped 50 million international packages in 2016, compared to 600 million from the Postal Service.

Dealing with such a massive quantity, he added, creates the need to “manage that risk and hone in our focus.”

Lawmakers on the House floor Thursday repeatedly shared stories of how the opioid crisis, and specifically synthetics such as fentanyl, had ravaged their districts. Still, the measure did not win universal support. Critics at hearings over the last two years have said that many countries do not have the capacity to provide the advanced data the bill would require and its passage would effectively shut off the shipping of packages to the United States from those areas. Rep. Danny Davis, D-Ill., voted for an earlier version of the measure in committee but on the floor criticized the latest iteration after he said Republican leadership insisted on the civil penalties on USPS without assessing their impact.

Paul Steidler, a senior fellow at the Lexington Institute, a right-leaning think tank that has for years sounded the alarm on the Postal Service’s role in bringing opioids into the country, said trends in international mailing will require most nations to collect and transmit AED within the next five to 10 years. In the meantime, he said, mailers from any country will be able to pay extra fees to send their packages to the United States, making any concerns on that topic illegitimate.

“These are very reasonable measures that need to be completed,” Steidler said.

Rep. Mike Bishop, R-Mich., who authored the bill, said when the bipartisan agreement was announced that it would “ensure our law enforcement has all the tools they need to keep this poison out of the hands of our children and our communities.”

“This common-sense legislation will close loopholes in the international mail system currently being exploited by drug traffickers to ship dangerous synthetic opioids, like fentanyl, across our borders,” Bishop said.

USPS itself declined to offer a full endorsement of the bill, saying it would “work collaboratively” with lawmakers and other stakeholders to “offer helpful suggestions on the bill text.”

“The Postal Service shares the deep concern of the Congress and the administration about America's opioid crisis,” said Dave Partenheimer, a USPS spokesman. “As we have done throughout our history, the Postal Service is committed to taking all practicable measures to ensure our nation's mail security, and provide the American public the best, most efficient service possible.”

The White House is supportive of the bill.

“This bill would improve the security of the international mail system to prevent abuses by those who would use it to smuggle dangerous opioids and other illicit substances into the United States,” the administration said in a statement.

President Trump laid out his Initiative to Stop Opioid Abuse in March, which included suggestions similar to those in the House-backed bill. The federal government continues to attack the issue from many angles, including efforts to stop the problem at the source. The DEA, for example, has grown its presence in China and is working with its counterparts there to crack down on manufacturers of opioid synthetics that are common in the country. The agency has set up an exchange program of chemists to identify and share emerging trends, as manufacturers are constantly altering the compounds that make up the drugs.

The House bill will now head to the Senate, where it already has bipartisan backing. Sen. Rob Portman, R-Ohio, who has championed the issue for multiple sessions of Congress, said he would ensure the measure gets signed into law “in the coming weeks.”

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.